The purpose of this study is to investigate gastrointestinal tract tumors. It focuses on the use of ctDNA in managing these conditions.
This study evaluates circulating biomarkers like ctDNA to improve diagnosis and treatment processes for gastrointestinal tract tumors.
- Who can participate: Adults over 18 with gastrointestinal cancer, such as esophageal, gastric, or pancreatic, may participate. Participants need adequate organ function and available tumor histological material.
- Study details: Participants will provide blood and fecal samples to study circulating tumor DNA (ctDNA). This study does not involve investigational drugs.